Circulating non-HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease

被引:18
|
作者
Zhu, Cheng-Gang [1 ]
Zhang, Yan [1 ]
Xu, Rui-Xia [1 ]
Li, Sha [1 ]
Wu, Na-Qiong [1 ]
Guo, Yuan-Lin [1 ]
Sun, Jing [1 ]
Li, Jian-Jun [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Div Dyslipidemia, State Key Lab Cardiovasc Dis,FuWai Hosp,Natl Ctr, Beijing 100037, Peoples R China
基金
北京市自然科学基金; 高等学校博士学科点专项科研基金;
关键词
Coronary artery disease; Non-HDL-C; LDL-C; Lipoprotein subfraction; ISCHEMIC-HEART-DISEASE; SMALL DENSE LDL; CARDIOVASCULAR-DISEASE; REMNANT CHOLESTEROL; PCSK9; LEVELS; RISK-FACTOR; ASSOCIATION; MANAGEMENT; RECOMMENDATIONS; DYSLIPIDEMIA;
D O I
10.1016/j.jacl.2015.08.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Conflicting results have been yielded as to whether low-density lipoprotein (LDL) cholesterol (LDL-C) or non-high-density lipoprotein (HDL) cholesterol (non-HDL-C) is a better marker of coronary artery disease (CAD) risk. Recently, plasma LDL and HDL subfractions have been suggested to be more accurately reflecting the lipoproteins' atherogenicity. OBJECTIVE: We sought to compare the relationship between LDL-C or non-HDL-C and lipoprotein subfractions. METHODS: We conducted a cross-sectional study in 351 consecutive stable CAD patients without lipid-lowering therapy. The LDL and HDL separations were performed using the Lipoprint System. The LDL-C levels were measured directly, and the non-HDL-C levels were calculated. RESULTS: The cholesterol concentrations of LDL (large, medium, and small) and HDL (small) particles were increased (all P < .001) by non-HDL-C or LDL-C quartiles, whereas the mean LDL particle size and cholesterol concentrations of HDL (large) were decreased (both P < .001) by non-HDL-C quartiles. In age- and gender-adjusted analysis, the cholesterol in small LDL was much strongly related to non-HDL-C than to LDL-C (r = 0.539 vs 0.397, both P < .001). Meanwhile, the mean LDL particle size was more closely associated with non-HDL-C than LDL-C (r = -0.336 vs r = -0.136, both P < .05). Significantly, the cholesterol in large HDL was negatively correlated with non-HDL-C (r = -0223, P < .001) but not with LDL-C. These correlations were further confirmed by the fully adjusted multivariable linear regression analysis. CONCLUSIONS: Non-HDL-C, in comparison to LDL-C, was more relevant to atherogenic lipoprotein subfractions in patients with stable CAD, supporting that it may be better in assessing cardiovascular risk. (C) 2015 National Lipid Association. All rights reserved.
引用
收藏
页码:794 / 800
页数:7
相关论文
共 50 条
  • [31] CORRELATION OF NON-HDL-C AND LDL-C WITH APOB DURING LIPID-LOWERING THERAPY IN PATIENTS WITH COMBINED HYPERLIPIDEMIA (HL)
    Grundy, S.
    Vega, G.
    Tomassini, J.
    Tershakovec, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [33] Comparison of the Reductions in LDL-C and Non-HDL-C Induced by the Red Yeast Rice Extract Xuezhikang Between Fasting and Non-fasting States in Patients With Coronary Heart Disease
    Zhu, Li-Yuan
    Wen, Xing-Yu
    Xiang, Qun-Yan
    Guo, Li-Ling
    Xu, Jin
    Zhao, Shui-Ping
    Liu, Ling
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [34] Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression
    Masson, Walter
    Siniawski, Daniel
    Lobo, Martin
    Molinero, Graciela
    Giorgi, Mariano
    Huerin, Melina
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2015, 105 (01) : 11 - 19
  • [35] Utility of Non-hdl-c and Apob Targets at Progressively Lower Ldl-c Down to Levels Less Than 40 Mg/dl
    Sathiyakumar, Vasanth
    Park, Jihwan
    Sajja, Aparna
    Guallar, Eliseo
    Lazo, Mariana
    Jones, Steven R.
    Martin, Seth S.
    CIRCULATION, 2019, 140
  • [36] MHR and NHR but not LHR were associated with coronary artery disease in patients with chest pain with controlled LDL-C
    Liu, Mengping
    Liu, Xiaojun
    Wei, Zhen
    Hua, Rui
    Huang, Yuzhi
    Hao, Xiang
    Yuan, Zuyi
    Zhou, Juan
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (07) : 1501 - 1507
  • [37] Prediction of CV events in statin-treated stable coronary patients by 16 novel biomarkers compared to LDL-C and HDL-C
    Larosa, J. C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 643 - 643
  • [38] Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease
    Lin, Taiwu
    Wang, Luzhao
    Guo, Jingbin
    Liu, Peng
    Chen, Liheng
    Wei, Mengqiu
    Li, Gongxin
    ANGIOLOGY, 2018, 69 (08) : 724 - 729
  • [39] Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes
    Weinstock, Ruth S.
    Goldberg, Ronald B.
    Guyton, John R.
    Mazzone, Theodore
    Polis, Adam
    Tomassini, Joanne E.
    Lin, Jianxin
    Shah, Arvind
    Tershakovec, Andrew M.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2008, 2 (01) : 25 - 35
  • [40] Differences in the correlations of non-HDL-c and LDL-c with apolipoprotein B in patients receiving pravastatin monotherapy or pravastatin plus cholestyramine.
    Gupta, EK
    Ito, MK
    PHARMACOTHERAPY, 2002, 22 (10): : 1333 - 1333